Oura Launches Menopause Insights and Birth Control Tracking Features

With the update, users can specify their birth control method and access biometric data to better understand how hormonal variations influence physiological metrics such as temperature trends, sleep patterns, and recovery indicators.

Wearable health company Oura has introduced two new hormonal health features, menopause insights and birth control tracking, expanding its focus on personalized women’s health monitoring.

The birth control feature is integrated into Oura’s existing Cycle Insights platform, which provides users with fertility signals, cycle phase tracking, and educational resources.

With the update, users can specify their birth control method and access biometric data to better understand how hormonal variations influence physiological metrics such as temperature trends, sleep patterns, and recovery indicators.

The platform also incorporates an in-app chatbot, Advisor, enabling users to interpret their data and identify what is typical for their individual health patterns. In addition, users can connect with licensed providers through Twentyeight Health for reproductive and sexual health support.

Oura has also launched Menopause Insights, supported by its Menopause Impact Scale (MIS), a questionnaire designed to assess quality of life across 22 symptoms associated with menopause. The feature combines self-reported inputs with continuous biometric data from the wearable device to generate personalized insights related to symptom patterns and overall well-being.

The update reflects a broader shift in digital health toward integrating condition-specific insights within wearable platforms, particularly in areas such as reproductive health and menopause, where continuous monitoring and personalized data interpretation remain limited.

Oura has been expanding its women’s health portfolio over the past year, including features focused on pregnancy tracking and partnerships with digital health providers such as Maven Clinic. The addition of menopause and birth control-related insights extends the platform’s coverage across multiple stages of reproductive health.

The company’s approach combines biometric tracking with self-reported data and access to clinical support, positioning wearable devices as tools for ongoing health monitoring beyond fitness and activity tracking.

Stay tuned for more such updates on Digital Health News